Skip to main content
. 2017 Feb 21;8(19):31355–31367. doi: 10.18632/oncotarget.15565

Table 3. Association of BRCA1 and ERCC1 and the effect of chemotherapy in primary nasopharyngeal carcinoma and cervical lymph node.

Expression Response
In primary N CR+PR SD+PD RR (%) X2 P1
BRCA1
+ 129 72 57 55.8 6.224 0.013
- 72 53 19 73.6
ERCC1
+ 136 77 59 56.6 7.795 0.005
- 65 50 15 76.9
BRCA1 ERCC1
+ + 103 54 49 52.4 12.840 0.005
- - 39 32 7 82.1
+ - 26 19 7 73.1
- + 33 23 10 69.6
In cervical lymph node
BRCA1
+ 129 86 43 66.6 4.387 0.036
- 72 58 14 80.5
ERCC1
+ 136 89 47 65.4 5.496 0.019
- 65 53 12 81.5
BRCA1 ERCC1
+ + 103 62 41 60.1 8.831 0.032
- - 39 33 6 84.6
+ - 26 20 6 76.9
- + 33 24 9 72.7

1Statistical analysis was estimated by χ2 test, and P < 0.05 was considered statistically significant; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease, RR, response rate.